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History.W er e p o r ta b o u tt h ec o u r s eo fc e n t r a ls l e e pa p n e a( C S A )i n3p a t i e n t s( 7 0 .3 ± 15.2years) with severe aortic stenosis (AS)
(AVA ≤ 1.0cm 2,N Y H A2 .7 ± 1.4). Investigations. Every patient received echocardiography, left/right-heart catheterization, and
cardiorespiratory polygraphy before and 6 months after surgical aortic valve replacement (without right-heart catheterization
during follow up). Course. Preoperatively all patients demonstrated reduced systolic left ventricular function (EF < 55%). They
had elevated pulmoraryarterialy pressures and severe CSA. After valve replacement left ventricular function and exercise capacity
improved, as well as the severity of CSA. Conclusion. Patients with severe AS can develop CSA, which seems to improve after
surgery. Patients with severe AS should be screened for CSA, because CSA might be an additional risk factor and hint that
myocardial adaptation is exhausting.
1.Introduction
Sleep disordered breathing (SDB) has a prognostic impact
on cardiac patients [1]. Development of CSA, particularly
Cheyne-Stokes respiration, because of secondary pulmonary
hypertension due to reduced left ventricular function is
known [2]. Advanced valvular heart disease with secondary
pulmonary hypertension due to impaired diastolic and/or
systolic function of the left ventricle may support the
occurrence of CSA. We examined three patients with aortic
stenosis (AS) before and after surgical valve replacement for
CSA.
2. Case Presentation
2.1. Case 1. Patient 1 reported about angina pectoris for
1-2 years (CCS II-III) and progredient dyspnea. Echocar-
diography revealed severe AS (AVA 0.8cm2, mean gradient
35mmHg). Left ventricular systolic function was reduced
to an ejection fraction of 50%. By heart catheterization an
additional two-vessel coronary artery disease (CAD) was
diagnosed.
2.2. Case 2. Patient 2 suﬀered from increasing dyspnea
(NYHA III). Echocardiography identiﬁed severe AS (AVA
1.0cm2, mean gradient 25mmHg). Left ventricular ejection
fraction was reduced to 40%. CAD was excluded by catheter-
ization.
2.3. Case 3. P a t i e n t3r e p o r t e da b o u tm o d e r a t ed y s p n e a
(NYHA II). Echocardiography demonstrated severe AS
(0.7cm2, mean gradient 44mmHg). By catheterization a
three-vessel CAD was found. Left ventricular ejection frac-
tion was low with 22%.
All sleep apnea examinations were done with a mobile
device during hospital stay (Embletta, Embla, Amsterdam).
A standard classiﬁcation was used for description of SDB
[3]. If thoracic and abdominal inspiration eﬀorts were
documented, SDB was considered to be obstructive (OSA),
otherwise central sleep apnea (CSA) was diagnosed. If both,
central and obstructive events were observed, OSA or CSA
was diagnosed according to the majority of either events (cut
oﬀ50%ofcentralversusobstructiveevents).Patientswithan
apnea-hypopnea-index (AHI) > 5/h were considered to have
SDB. An AHI ≥ 15/h indicates moderate SDB and necessity2 Case Reports in Medicine
(a)
(b)
Figure 1: Respiratory analysis of a patient before (a) and after (b) aortic valve replacement. (a) Typical breathing in CSA without respiration
eﬀorts (nasal airﬂow, abdominal and thoracic breathing eﬀorts, oxygen saturation, and heart rate are shown), (b) Only mild undulating
nocturnal respiration.
for therapy [3]. Continuous data are expressed as mean
value ± standard deviation (SD). Statistical analyses were
performed with the Statview software (SAS Corporation).
For continuous and normally distributed data, unpaired t-
tests, in case of non-normality of distribution Wilcoxon-
signed rank tests were used. A two-tailed P value < .05 was
considered signiﬁcant.
Before valve replacement all patients suﬀered from severe
CSA and had a mean AHI of 34 ± 41.5 /h (Table 1).
Mean pulmonary artery pressure was elevated to 36.7 ±
22.5mmHg. Six months after valve replacement in all
patientstheAHI-reducedsigniﬁcantly(meanAHI6.3 ±10.3
/h, P < .05) (Figure 1). Patient 3 still demonstrated a mild
OSA. Pulmonary artery pressure after valve replacement was
calculated by CW-Doppler of the regurgitation jet of the
tricuspid valve and was also decreased after surgery (21.7 ±
7.2mmHg, P = .05). After valve replacement left ventricular
ejection fraction improved considerably (mean LVEF 39%
versus 55%; P = ns) and was associated with better exercise
capacity (NYHA: 2.7 ± 1.4 versus 0.7 ± 1.4; P = .01).
3. Discussion
Recent studies demonstrated that occurrence and severity of
CSA are correlated to the severity of systolic and diastolic
left ventricular dysfunction [4]. The occurrence of CSA
is partially caused by secondary pulmonary hypertension
following diastolic and/or systolic left ventricular dysfunc-
tion [2]. In patients with severe valve disease, secondary
pulmonary hypertension due to exhaustion of myocardial
left ventricular function may induce CSA.Case Reports in Medicine 3
Table 1: Clinical, hemodynamic, echocardiographic, and sleep data before and after aortic valve replacement (AVR). BMI: body mass
index, AVA: aortic valve area, EF: ejection fraction, LVID(d/s): left ventricular diameter (end diastolic/end systolic), LVPWd: left ventricular
posterior wall thickness, PAM: mean pulmonary artery pressure, LVEDP: left ventricular enddiastolic pressure, SDB: sleep disordered
breathing, AHI: apnea/hypopnea-index.
patient 1
before AVR
patient 2
before AVR
patient 3
before AVR
patient 1 after
AVR
patient 2 after
AVR
patient 3 after
AVR P
BMI (kg/m2] 26,7 28,4 23,5 27,3 27,4 26,8 ns
AVA [cm2] 0,8 1,0 0,7 2,1 2,3 1,7 P < .05
Mean Gradient [mmHg] 35 25 44 9 6 20 P < .05
EF [%] 55 40 22 55 55 55 ns
LVIDd [mm] 49 51 72 48 49 54 ns
LVIDs [mm] 25 34 60 16 34 34 ns
LVPWd [mm] 13 10 12 9 9 12 ns
PAM [mmHg] 30 33 47 20 (Echo) 25 (Echo) 20 (Echo) P = .05
LVEDP [mmHg] 45 32 39
SDBAHI [/h] CSA16 CSA37 CSA49 None <5N o n e <5 OSA11 P < .05
We report about three patients with severe AS and CSA
before surgical valve replacement. Patient 1 had the best
systolicleftventricularfunctionanddemonstratedthelowest
severity of CSA. Before valve replacement all patients had
increased mean pulmonary artery and left end diastolic
pressure.
After valve replacement left ventricular function had
been normalized in all three patients. Echocardiography
revealed normal end diastolic and end systolic diameters and
a decrease of left ventricular hypertrophy in all patients. All
patients recovered from CSA postoperatively.
The relation between occurrence and severity of CSA to
occurrence and severity of pulmonary hypertension must be
veriﬁed in further studies. CSA was decreased or resolved
after improvement in cardiac function. This supports that
CSA is another manifestation of cardiac dysfunction. There-
fore, asymptomatic patients with moderate to severe AS
should be screened for the presence of CSA. Yet it is
unclear, if the development of CSA might be an early
and sensitive marker to detect myocardial maladaptation in
patients with so-far asymptomatic AS. Further controlled
studies with pre- and postoperative evaluations are war-
ranted.
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